XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

174 hedge funds and large institutions have $2.36B invested in Xenon Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 20 closing their positions.

Holders
174
Holders Change
+12
Holders Change %
+7.41%
% of All Funds
2.74%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
33
Increased
57
Reduced
56
Closed
20
Calls
$5.17M
Puts
$3.07M
Net Calls
+$2.1M
Net Calls Change
-$8.21M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$40.5M
2
Invesco
2
Invesco
Georgia
$26.9M
3
Fiera Capital (Canada)
3
Fiera Capital (Canada)
Quebec, Canada
$21.1M
4
APM
4
Avidity Partners Management
Texas
$18.5M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$200M

Top Sellers

1
LGM
1
Logos Global Management
California
$10.6M
2
PA
2
Perceptive Advisors
New York
$47.1M
3
Citadel Advisors
3
Citadel Advisors
Florida
$19.3M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$5.71M
5
Norges Bank
5
Norges Bank
Norway
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$200M 5,188,707 +460,858 +10%
ACA
2
Avoro Capital Advisors
New York
$189M 4,900,000 – –
DCM
3
Driehaus Capital Management
Illinois
$183M 4,760,853 +105,928 +2%
PCH
4
Polar Capital Holdings
United Kingdom
$116M 3,022,071 +5,253 +0.2%
Capital International Investors
5
Capital International Investors
California
$89.4M 2,321,991 – –
Marshall Wace
6
Marshall Wace
United Kingdom
$89.3M 2,320,419 -167 -0%
Capital World Investors
7
Capital World Investors
California
$87.6M 2,274,974 – –
PAMS
8
Pictet Asset Management (Switzerland)
Switzerland
$78.3M 2,032,730 +28,433 +1%
Lord, Abbett & Co
9
Lord, Abbett & Co
New Jersey
$75.4M 1,958,540 +175,929 +10%
CC
10
Commodore Capital
New York
$71M 1,845,000 – –
B
11
Braidwell
Connecticut
$70.4M 1,828,353 -308,757 -14%
BI
12
BVF Inc
California
$70.4M 1,827,958 – –
PA
13
Perceptive Advisors
New York
$47.1M 1,223,377 -608,797 -33%
RSCM
14
Rock Springs Capital Management
Maryland
$45.4M 1,178,002 – –
RG
15
Redmile Group
California
$43.1M 1,120,476 -205,356 -15%
O
16
OrbiMed
New York
$42.2M 1,096,000 -53,100 -5%
Wellington Management Group
17
Wellington Management Group
Massachusetts
$40.5M 1,051,051 +803,614 +325%
BlackRock
18
BlackRock
New York
$38.3M 994,040 +94,886 +11%
PBA
19
Paradigm Biocapital Advisors
New York
$38.1M 989,327 +338,259 +52%
SC
20
Samlyn Capital
New York
$36.2M 939,909 -219,085 -19%
NIP
21
Nicholas Investment Partners
California
$30.5M 791,118 +354,403 +81%
Loomis, Sayles & Company
22
Loomis, Sayles & Company
Massachusetts
$29M 753,526 -7,041 -0.9%
BBA
23
Baker Bros. Advisors
New York
$28.9M 751,639 – –
Holocene Advisors
24
Holocene Advisors
New York
$27.4M 712,478 -273,717 -28%
CS
25
Candriam SCA
Luxembourg
$27.2M 705,884 -13,322 -2%
1
2 3 4 5